awmsg logo



fampridine (Fampyra®)


Reference No. 3942


Appraisal information

fampridine (Fampyra®) 10 mg prolonged-release tablet


Company: Biogen Idec Ltd
BNF category: Musculoskeletal and joint diseases
NMG meeting date: 06/11/2019
AWMSG meeting date: 11/12/2019
   
   
Submission Type: Full Submission
Status: In progress
Advice No: Not available
Ratification by Welsh Government: Not available

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

Indication

Improvement of walking in adult patients with multiple sclerosis with walking disability (Expanded Disability Status Scale 4–7)
AWMSG Secretariat Appraisal Report (ASAR)
Download
Preliminary Appraisal Recommendation (PAR)
Download
Company Response to the Preliminary Appraisal Recommendation (CR PAR)
Download